Twist Current Deferred Revenue vs Non Current Assets Total Analysis

TWST Stock

USD 47.01 0.51 1.10%

Twist Bioscience financial indicator trend analysis is much more than just breaking down Twist Bioscience Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Twist Bioscience Corp is a good investment. Please check the relationship between Twist Bioscience Current Deferred Revenue and its Non Current Assets Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Current Deferred Revenue vs Non Current Assets Total

Current Deferred Revenue vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Twist Bioscience Corp Current Deferred Revenue account and Non Current Assets Total. At this time, the significance of the direction appears to have strong relationship.

The correlation between Twist Bioscience's Current Deferred Revenue and Non Current Assets Total is 0.77. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Twist Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Twist Bioscience's Current Deferred Revenue and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Twist Bioscience Corp are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Current Deferred Revenue i.e., Twist Bioscience's Current Deferred Revenue and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.77

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from Twist Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, Twist Bioscience's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.19 in 2024, whereas Selling General Administrative is likely to drop slightly above 109.9 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	333.3M	296.6M	341.1M	170.8M
Cost Of Revenue	119.3M	155.4M	178.7M	187.6M

Total Operating Expenses Cost Of Revenue

Twist Bioscience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory
Total Assets		0.9	0.7	0.99	0.94	0.27	0.91	0.89	0.65	-0.85	-0.93	0.94	0.93	0.87	0.83	0.26	-0.88	0.96	0.9	0.83	0.98	0.39	-0.75	-0.53	0.92	0.94
Short Long Term Debt Total	0.9		0.59	0.89	0.96	0.11	0.98	1.0	0.8	-0.76	-0.96	0.83	0.82	0.99	0.75	0.09	-0.84	0.84	0.98	0.97	0.9	0.32	-0.72	-0.45	0.98	0.97
Other Current Liab	0.7	0.59		0.7	0.64	0.02	0.57	0.62	0.05	-0.62	-0.56	0.72	0.64	0.61	0.32	0.01	-0.51	0.7	0.53	0.59	0.56	0.4	-0.41	-0.23	0.57	0.66
Total Current Liabilities	0.99	0.89	0.7		0.93	0.24	0.91	0.89	0.65	-0.84	-0.94	0.97	0.92	0.88	0.85	0.24	-0.89	0.95	0.9	0.84	0.98	0.4	-0.75	-0.54	0.92	0.94
Total Stockholder Equity	0.94	0.96	0.64	0.93		0.24	0.99	0.95	0.77	-0.82	-0.96	0.88	0.87	0.93	0.77	0.22	-0.93	0.93	0.97	0.89	0.92	0.48	-0.87	-0.65	0.99	0.98
Other Liab	0.27	0.11	0.02	0.24	0.24		0.15	0.03	0.22	-0.67	-0.13	0.29	0.57	0.0	0.43	1.0	-0.29	0.45	0.11	-0.08	0.23	-0.21	-0.23	-0.21	0.16	0.26
Net Tangible Assets	0.91	0.98	0.57	0.91	0.99	0.15		0.97	0.82	-0.76	-0.97	0.85	0.82	0.96	0.77	0.14	-0.91	0.88	0.99	0.93	0.92	0.44	-0.84	-0.61	1.0	0.97
Property Plant And Equipment Net	0.89	1.0	0.62	0.89	0.95	0.03	0.97		0.78	-0.72	-0.96	0.83	0.79	1.0	0.73	0.02	-0.83	0.81	0.97	0.99	0.89	0.33	-0.71	-0.44	0.98	0.96
Current Deferred Revenue	0.65	0.8	0.05	0.65	0.77	0.22	0.82	0.78		-0.56	-0.83	0.59	0.61	0.77	0.79	0.22	-0.78	0.61	0.85	0.75	0.75	0.19	-0.66	-0.49	0.84	0.77
Net Debt	-0.85	-0.76	-0.62	-0.84	-0.82	-0.67	-0.76	-0.72	-0.56		0.76	-0.87	-0.97	-0.7	-0.8	-0.66	0.78	-0.92	-0.73	-0.64	-0.79	-0.12	0.61	0.4	-0.77	-0.87
Retained Earnings	-0.93	-0.96	-0.56	-0.94	-0.96	-0.13	-0.97	-0.96	-0.83	0.76		-0.88	-0.83	-0.95	-0.85	-0.13	0.92	-0.87	-0.98	-0.92	-0.95	-0.39	0.76	0.52	-0.98	-0.96
Accounts Payable	0.94	0.83	0.72	0.97	0.88	0.29	0.85	0.83	0.59	-0.87	-0.88		0.92	0.83	0.86	0.31	-0.86	0.92	0.84	0.79	0.91	0.29	-0.67	-0.45	0.87	0.92
Cash	0.93	0.82	0.64	0.92	0.87	0.57	0.82	0.79	0.61	-0.97	-0.83	0.92		0.77	0.85	0.55	-0.81	0.95	0.8	0.72	0.89	0.17	-0.65	-0.43	0.83	0.91
Non Current Assets Total	0.87	0.99	0.61	0.88	0.93	0.0	0.96	1.0	0.77	-0.7	-0.95	0.83	0.77		0.72	-0.02	-0.8	0.79	0.96	0.99	0.87	0.29	-0.68	-0.41	0.96	0.95
Non Currrent Assets Other	0.83	0.75	0.32	0.85	0.77	0.43	0.77	0.73	0.79	-0.8	-0.85	0.86	0.85	0.72		0.45	-0.85	0.81	0.8	0.68	0.9	0.13	-0.56	-0.36	0.8	0.83
Other Assets	0.26	0.09	0.01	0.24	0.22	1.0	0.14	0.02	0.22	-0.66	-0.13	0.31	0.55	-0.02	0.45		-0.3	0.44	0.11	-0.09	0.23	-0.2	-0.22	-0.2	0.15	0.26
Long Term Debt	-0.88	-0.84	-0.51	-0.89	-0.93	-0.29	-0.91	-0.83	-0.78	0.78	0.92	-0.86	-0.81	-0.8	-0.85	-0.3		-0.91	-0.93	-0.74	-0.91	-0.58	0.82	0.64	-0.92	-0.9
Cash And Short Term Investments	0.96	0.84	0.7	0.95	0.93	0.45	0.88	0.81	0.61	-0.92	-0.87	0.92	0.95	0.79	0.81	0.44	-0.91		0.86	0.72	0.93	0.45	-0.78	-0.59	0.88	0.92
Net Receivables	0.9	0.98	0.53	0.9	0.97	0.11	0.99	0.97	0.85	-0.73	-0.98	0.84	0.8	0.96	0.8	0.11	-0.93	0.86		0.93	0.92	0.45	-0.78	-0.54	0.99	0.97
Good Will	0.83	0.97	0.59	0.84	0.89	-0.08	0.93	0.99	0.75	-0.64	-0.92	0.79	0.72	0.99	0.68	-0.09	-0.74	0.72	0.93		0.83	0.25	-0.63	-0.36	0.93	0.92
Common Stock Shares Outstanding	0.98	0.9	0.56	0.98	0.92	0.23	0.92	0.89	0.75	-0.79	-0.95	0.91	0.89	0.87	0.9	0.23	-0.91	0.93	0.92	0.83		0.39	-0.74	-0.52	0.93	0.93
Short Term Investments	0.39	0.32	0.4	0.4	0.48	-0.21	0.44	0.33	0.19	-0.12	-0.39	0.29	0.17	0.29	0.13	-0.2	-0.58	0.45	0.45	0.25	0.39		-0.62	-0.64	0.42	0.33
Long Term Debt Total	-0.75	-0.72	-0.41	-0.75	-0.87	-0.23	-0.84	-0.71	-0.66	0.61	0.76	-0.67	-0.65	-0.68	-0.56	-0.22	0.82	-0.78	-0.78	-0.63	-0.74	-0.62		0.94	-0.81	-0.74
Non Current Liabilities Total	-0.53	-0.45	-0.23	-0.54	-0.65	-0.21	-0.61	-0.44	-0.49	0.4	0.52	-0.45	-0.43	-0.41	-0.36	-0.2	0.64	-0.59	-0.54	-0.36	-0.52	-0.64	0.94		-0.57	-0.49
Capital Surpluse	0.92	0.98	0.57	0.92	0.99	0.16	1.0	0.98	0.84	-0.77	-0.98	0.87	0.83	0.96	0.8	0.15	-0.92	0.88	0.99	0.93	0.93	0.42	-0.81	-0.57		0.98
Inventory	0.94	0.97	0.66	0.94	0.98	0.26	0.97	0.96	0.77	-0.87	-0.96	0.92	0.91	0.95	0.83	0.26	-0.9	0.92	0.97	0.92	0.93	0.33	-0.74	-0.49	0.98

Click cells to compare fundamentals

Twist Bioscience Account Relationship Matchups

Twist Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Short Long Term Debt Total	36.0M	62.9M	94.9M	94.1M	108.2M	113.6M
Other Current Liab	2.6M	9.6M	53.5M	7.8M	9.0M	11.3M
Total Current Liabilities	36.0M	63.1M	90.7M	73.3M	84.3M	45.4M
Total Stockholder Equity	336.3M	580.8M	789.4M	623.4M	716.9M	752.8M
Other Liab	158K	351K	5.1M	60K	69K	65.6K
Net Tangible Assets	150.4M	334.8M	540.1M	789.4M	907.8M	953.2M
Property Plant And Equipment Net	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Current Deferred Revenue	18.8M	28.8M	3.5M	36.6M	42.1M	44.2M
Net Debt	(57.7M)	(402.9M)	(283.8M)	(192.4M)	(173.2M)	(181.8M)
Retained Earnings	(458.5M)	(610.6M)	(828.4M)	(1.0B)	(929.7M)	(883.2M)
Accounts Payable	4.8M	14.9M	20.1M	14.1M	16.2M	10.5M
Cash	93.7M	465.8M	378.7M	286.5M	329.4M	194.1M
Non Current Assets Total	64.0M	155.6M	364.9M	352.1M	405.0M	425.2M
Non Currrent Assets Other	3.4M	9.2M	5.0M	8.5M	9.8M	5.2M
Other Assets	4.4M	3.4M	49.9M	(1K)	(1.2K)	(1.1K)
Cash And Short Term Investments	290.0M	477.9M	505.0M	336.4M	386.9M	267.6M
Net Receivables	26.4M	28.5M	40.3M	44.1M	50.7M	53.2M
Common Stock Shares Outstanding	39.2M	48.3M	53.9M	56.9M	65.4M	39.9M
Short Term Investments	196.3M	12.0M	126.3M	49.9M	57.4M	73.5M
Liabilities And Stockholders Equity	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Non Current Liabilities Total	26.6M	58.2M	81.3M	79.6M	71.7M	90.3M
Capital Surpluse	470.4M	794.6M	1.2B	1.6B	1.9B	2.0B
Inventory	12.3M	31.8M	39.3M	32.1M	36.9M	38.7M
Other Current Assets	6.2M	8.3M	11.9M	11.7M	13.5M	14.1M
Other Stockholder Equity	794.6M	1.2B	1.6B	1.7B	1.9B	2.0B
Total Liab	62.6M	121.3M	172.0M	153.0M	137.7M	123.3M
Property Plant And Equipment Gross	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Total Current Assets	334.9M	546.5M	596.5M	424.3M	487.9M	314.2M
Non Current Liabilities Other	25.2M	58.2M	60K	475K	546.3K	518.9K
Short Term Debt	9.7M	9.8M	13.6M	14.9M	17.1M	8.9M
Intangible Assets	307K	18.3M	59.7M	54.5M	62.7M	65.8M
Property Plant Equipment	20.8M	25.5M	44.1M	214.4M	246.5M	258.9M
Net Invested Capital	341.0M	1.6M	789.4M	623.4M	716.9M	752.8M

When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:

How To Invest In Twist

Details

Is Twist Stock a good investment?

Details

What is Twist Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

	Transaction History View history of all your transactions and understand their impact on performance
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.36)

Revenue Per Share

4.834

Quarterly Revenue Growth

0.251

Return On Assets

(0.16)

Return On Equity

(0.30)

The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Twist Current Deferred Revenue vs Non Current Assets Total Analysis

Current Deferred Revenue vs Non Current Assets Total

Current Deferred Revenue vs Non Current Assets Total Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Non Current Assets Total

Twist Bioscience fundamental ratios Correlations

Twist Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Twist Bioscience fundamental ratios Accounts

Complementary Tools for Twist Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Short Long Term Debt Total
Other Assets	+ 1.0	Other Liab
Capital Surpluse	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Short Long Term Debt Total

Capital Surpluse	- 0.98	Retained Earnings
Net Receivables	- 0.98	Retained Earnings
Cash	- 0.97	Net Debt
Retained Earnings	- 0.97	Net Tangible Assets
Inventory	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Property Plant And Equipment Net